TCRT
Alaunos Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.30
+0.11 ▲ +3.45%
🌙 3월 13일 7:14 PM ET (한국 3/14 08:14)
$3.40
+0.10 ▲ +3.03%
| Index | - | P/E | - | EPS (ttm) | -2.31 | Insider Own | 16.35% | Shs Outstand | 0.00B | Perf Week | -8.59% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 25% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 4.86% | Short Float | 1.83% | Perf Quarter | -23.43% |
| Income | -0.00B | P/S | 737 | EPS this Y | - | Inst Trans | 8.19% | Short Ratio | 1.22 | Perf Half Y | 38.66% |
| Sales | 0.00B | P/B | 2.6 | EPS next 5Y | - | ROA | -110.67% | Short Interest | 0.03M | Perf YTD | 2.17% |
| Book/sh | 1.27 | P/C | 3.8 | EPS past 3/5Y | 62.43% 51.16% | ROE | -145.65% | 52W High | -46.77% ($6.20) | Perf Year | 122.97% |
| Cash/sh | 0.87 | P/FCF | - | Sales past 3/5Y | -70.71% - | ROIC | -145.09% | 52W Low | 151.2% ($1.31) | Perf 3Y | -95.71% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 68.59% | Gross Margin | - | Volatility(W/M) | 7.09% 7.58% | Perf 5Y | -99.5% |
| Dividend TTM | - | EV/Sales | 543 | Sales Y/Y TTM | - | Oper. Margin | -67883.33% | ATR (14) | 0.24 | Perf 10Y | -99.74% |
| Dividend Ex-Date | - | Quick Ratio | 2.92 | EPS Q/Q | 21.82% | Profit Margin | -67783.33% | RSI (14) | 55.9 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.92 | Sales Q/Q | - | SMA20 | 5.98% ($3.11) | Beta | -1.2 | Target Price | $1125 |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 11.14% ($2.97) | Rel Volume | 0.68 | Prev Close | $3.19 |
| Employees | 1 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -14.29% - | SMA200 | 7.22% ($3.08) | Avg Volume(3M) | 0.03M | Price | $3.3 |
| IPO | 2005/8/22 | Option/Short | No/Yes | Trades | 153 | Volume | 18,998 | Change | 3.45% |
뉴스 로딩 중...